The Republican-led Congress and Democratic White House just closed out a surprisingly productive year in 2015, marked by the long-fought repeal of the Medicare physician payment system and passage of a $1.15 trillion spending bill that included a $2-billion increase for the National Institutes of Health (NIH) – two of the Endocrine Society’s top legislative...
The Endocrine Society increasingly is called to contribute to policy discussions in the U.S. and globally concerning regulation of endocrine disrupting chemicals (EDCs). The Society’s goal in reaching out to regulators, policymakers, and other stakeholders is to ensure that regulatory decisions involving EDCs incorporate relevant endocrine principles and are informed by modern endocrine science. In...
After much debate and negotiation, Congress reached a compromise on the fiscal year (FY) 2016 appropriations bill that will finalize the budgets for the National Institutes of Health (NIH) and other research agencies through September. The bill includes $32 billion for NIH (a $2 billion increase), the amount recommended by the Endocrine Society. The omnibus...
The Endocrine Society increasingly is called to contribute to policy discussions in the U.S. and globally concerning regulation of endocrine-disrupting chemicals (EDCs). The Society’s goal in reaching out to regulators, policymakers, and other stakeholders is to ensure that regulatory decisions involving EDCs incorporate relevant endocrine principles and are informed by modern endocrine science. In November...
As this item is posted, the fate of the fiscal year (FY) 2016 budget for the National Institutes of Health (NIH) remains uncertain. While Congress was able to reach a budget agreement in September that raises the amount of spending allowed and opens the door for an increase for NIH and other programs, Congress is...
On November 4, in conjunction with Diabetes Awareness Month, the Society held a Congressional briefing to highlight what policymakers can do to improve diabetes care in the U.S. The briefing featured Ann Albright, PhD, RD, director of the Division of Diabetes Translation at the Centers for Disease Control and Prevention (CDC), who detailed the scope...
November is World Diabetes Month — a critical opportunity to highlight the more than 380 million individuals who suffer from diabetes globally. In the U.S., the incidence of the disease continues to rise and is the seventh leading cause of death. While the Endocrine Society will be participating in a number of activities this month to promote the global awareness campaign, it...
The Endocrine Society is hosting a Congressional briefing on November 4 to examine policies to help the 29 million Americans who have diabetes and the 86 million who are likely to develop the disease. A diabetes diagnosis affects an individual’s overall health and quality of life, and the condition is costly to treat. The nation’s...
Not all topics of relevance to endocrinologists are about specific conditions and diseases. Sometimes, doctors need information about changes in the medical field or the field of endocrinology. Changes to medical insurance legislation, drug trial regulations and even patient privacy legislation all impact a practitioner’s way of doing business and practicing medicine. Yet keeping track of these details is not always easy. That’s why Endocrine News has organized articles and news pieces on these topics into this advocacy page. Here, practitioners can find the information gathered by the Endocrine Society, a leading endocrinology advocacy organization, conveniently in one location.
Important Advocacy Information From the Endocrine Society
As an endocrinology advocacy organization, the Endocrine Society is constantly working to advocate for endocrinologists and their patients, both in the government and in various research centers across the country. Here on Endocrine News, you can stay informed about these efforts and their results, so you are well aware of what changes may be coming that affect your practice. This is an invaluable resource for doctors who wish to spend their time focusing on their patients, rather than advocating for their practices, but also wish to stay informed about what is happening in the field.
Both Clinical and Research Advocacy Information
On the Advocacy page, Endocrine News provides advocacy information relevant to both those in the research field and those practicing on a clinical level. Stay up to date with the activities of the Endocrine Society, learn more about the legislation that affects your work, and see highlights of leading researchers who are pioneering not only advances in the practice but also advocacy for endocrinology as a field. By utilizing the resources on the Advocacy page, you will be better equipped to meet the needs of your patients while staying abreast on the changes affecting the industry.
The Republican-led Congress and Democratic White House just closed out a surprisingly productive year in 2015, marked by the long-fought repeal of the Medicare physician payment system and passage of a $1.15 trillion spending bill that included a $2-billion increase for the National Institutes of Health (NIH) – two of the Endocrine Society’s top legislative...
